Stock Research for OVAS


Featured Broker: Ally Invest

Get the due diligence for another stock.


OVAS Stock Chart & Research Data

The OVAS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OVAS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


OVAS Due diligence Resources & Stock Charts

The OVAS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View OVAS Detailed Price Forecast - CNN Money CNN View OVAS Detailed Summary - Google Finance
Yahoo View OVAS Detailed Summary - Yahoo! Finance Zacks View OVAS Stock Research & Analysis -

Stock Analysis

TradeIdeas View OVAS Trends & Analysis - Trade-Ideas Barrons View OVAS Major Holders - Barrons
NASDAQ View OVAS Call Transcripts - NASDAQ Seeking View OVAS Breaking News & Analysis - Seeking Alpha
Spotlight View OVAS Annual Report - OTC Report View OVAS OTC Short Report -
TradeKing View OVAS Fundamentals - TradeKing Charts View OVAS SEC Filings - Bar Chart
WSJ View Historical Prices for OVAS - The WSJ Morningstar View Performance/Total Return for OVAS - Morningstar
MarketWatch View the Analyst Estimates for OVAS - MarketWatch CNBC View the Earnings History for OVAS - CNBC
StockMarketWatch View the OVAS Earnings - StockMarketWatch MacroAxis View OVAS Buy or Sell Recommendations - MacroAxis
Bullish View the OVAS Bullish Patterns - American Bulls Short Pains View OVAS Short Pain Metrics -

Social Media Mentions

StockTwits View OVAS Stock Mentions - StockTwits PennyStocks View OVAS Stock Mentions - PennyStockTweets
Twitter View OVAS Stock Mentions - Twitter Invest Hub View OVAS Investment Forum News - Investor Hub
Yahoo View OVAS Stock Mentions - Yahoo! Message Board Seeking Alpha View OVAS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for OVAS - Insider Cow View Insider Transactions for OVAS - Insider Cow
CNBC View OVAS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for OVAS - OTC Markets
Yahoo View Insider Transactions for OVAS - Yahoo! Finance NASDAQ View Institutional Holdings for OVAS - NASDAQ

Stock Charts

FinViz View OVAS Stock Insight & Charts - StockCharts View OVAS Investment Charts -
BarChart View OVAS Stock Overview & Charts - BarChart Trading View View OVAS User Generated Charts - Trading View

Latest Financial News for OVAS

Free Technical Research on OPKO Health and Three More Biotech Equities
Posted on Tuesday July 17, 2018

On Monday, July 16, 2018, the NASDAQ Composite and the S&P 500 edged 0.26% and 0.10% lower, respectively at the closing bell, while the Dow Jones Industrial Average stayed bullish, finishing marginally higher by 0.18%. Taking into consideration yesterday's market sentiment, assessed the following Biotechnology equities this morning: Onconova Therapeutics Inc. (NASDAQ: ONTX), Ophthotech Corp. (NASDAQ: OPHT), OPKO Health Inc. (NASDAQ: OPK), and OvaScience Inc. (NASDAQ: OVAS).

Edited Transcript of OVAS earnings conference call or presentation 9-May-17 8:30pm GMT
Posted on Thursday July 12, 2018

Q1 2017 OvaScience Inc Earnings Call

Flavor Of The Month: OvaScience And More
Posted on Monday May 07, 2018

OvaScience and Nabriva Therapeutics can add profound upside to your portfolio. This is because the optimistic growth outlook for their profitability and returns make their high-growth potential appealing relative toRead More...

OvaScience: 1Q Earnings Snapshot
Posted on Thursday May 03, 2018

On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 21 cents. Losses, adjusted for restructuring costs, came to 19 cents per share. The infertility treatment company posted ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.